1 Two cases of delayed-onset suicidal ideation, dysphoria and anxiety after ketamine infusion in patients with obsessive-compulsive disorder and a history of major depressive disorder Journal of Psychopharmacology, May 20, 2013
2 Efficacy and tolerability of asenapine for acute mania in bipolar I disorder: meta-analyses of randomized-controlled trials International Clinical Psychopharmacology, May 30, 2013 Evidence Based Medicine Review Article
3 Efficacy of olanzapine monotherapy in acute bipolar depression: A pooled analysis of controlled studies Journal of Affective Disorders, June 3, 2013
4 Mood disorders and complementary and alternative medicine: a literature review Neuropsychiatric Disease and Treatment, May 29, 2013 Review Article
5 A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania Australian and New Zealand Journal of Psychiatry, June 6, 2013
6 Efficacy and safety of fluoxetine monotherapy in bipolar depression: a systematic review Expert Opinion on Pharmacotherapy, May 21, 2013
7 Understanding treatment non-adherence in schizophrenia and bipolar disorder: a survey of what service users do and why BMC Psychiatry, May 31, 2013 Continuing Medical Education
8 Significant sleep disturbances in euthymic bipolar patients Comprehensive Psychiatry, May 23, 2013
9 Should an assessment of Axis I comorbidity be included in the initial diagnostic assessment of mood disorders? Role of QIDS-16-SR total score in predicting number of Axis I comorbidity Journal of Affective Disorders, May 23, 2013
10 The impact of limbic system morphology on facial emotion recognition in bipolar I disorder and healthy controls Neuropsychiatric Disease and Treatment, May 23, 2013
Sponsor
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor